Close

Collegium Pharma (COLL) Prices 5M Share Stock Offering for Proceeds of $80M

Go back to Collegium Pharma (COLL) Prices 5M Share Stock Offering for Proceeds of $80M

Collegium Prices Public Offering of $80 million of Common Stock

October 26, 2016 9:00 AM EDT

CANTON, Mass., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced the pricing of its previously announced public offering of 5,000,000 shares of its common stock at a price to the public of $16.00 per share.  In addition, Collegium has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of its common stock offered in the public offering on the same terms and conditions.  The gross proceeds of this offering are expected to be $80 million, excluding underwriters discounts and commissions and any exercise of the underwriters option to purchase an additional... More

Collegium Announces Proposed Public Offering of Common Stock

October 25, 2016 4:02 PM EDT

CANTON, Mass., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are being sold by Collegium.  In addition, Collegium has granted the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering.

Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers.

Collegium intends to use the net proceeds from this offering for the continued... More